SCHEMBL6943393

SCHEMBL6943393

CC(C)c1cccc(C(C)C)c1NC(=O)Nc1ccccc1Oc1ccc(N)cc1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 8/20 0.67
LMNA P02545 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 2/20 0.46
POLB P06746 1/20 0.46
EPHX2 P34913 1/20 0.45
P2RY1 P47900 2/20 0.44
ADRA2C P18825 1/20 0.43
P2RY2 P41231 1/20 0.43
P2RY14 Q15391 1/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
RECQL P46063 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6939932 0.84 LPAR1 (0.62) LPAR1LMNAL3MBTL1POLBKMT2A
SCHEMBL7070334 0.84 GAA (0.56) LPAR1LMNAL3MBTL1CA12CA1
SCHEMBL6943396 0.77 ALDH1A1 (0.61) LMNAL3MBTL1CA12CA1CA2
SCHEMBL4865713 0.76 ADRA2C (0.54) LMNAL3MBTL1CA12CA1CA2
SCHEMBL7950202 0.74 NCOA1 (0.51) L3MBTL1POLBKMT2AMEN1
SCHEMBL462304 0.74 LPAR1 (0.66) LPAR1LMNAKMT2AMEN1
SCHEMBL6943804 0.73 P2RY1 (0.58) L3MBTL1CA12CA1CA2CA9
SCHEMBL8103125 0.72 P2RY1 (0.55) LMNAL3MBTL1CA12CA1CA2
SCHEMBL19538842 0.69 L3MBTL1 (0.76) LMNAL3MBTL1CA12CA1CA2
SCHEMBL9435674 0.69 KMT2A (0.63) LPAR1LMNAEPHX2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042278-B1 1,3-DISUBSTITUTED UREAS AS ACAT INHIBITORS, AND METHOD OF PREPARING THEREOF SLOVAKOFARMA AS (SK) 2003-03-05 EP disclosed
US-6444691-B1 ANTICHOLESTEROL AGENTS SOLVAKOFARMA, A.S. (SK) 2002-09-03 US disclosed
EP-1042278-A1 1,3-DISUBSTITUTED UREAS AS ACAT INHIBITORS, AND METHOD OF PREPARING THEREOF Slovakofarma, A.S. (SK) 2000-10-11 EP disclosed
WO-1999032437-A1 1,3-DISUBSTITUTED UREAS AS ACAT INHIBITORS, AND METHOD OF PREPARING THEREOF SLOVAKOFARMA, A.S. (SK) 1999-07-01 WO disclosed